跳至主要内容
临床试验/ACTRN12612001120864
ACTRN12612001120864已完成3 期

Randomised controlled trial of early use of a simplified treatment regimen incorporating a half-dose, three-in-one blood pressure lowering pill vs. usual care for improving hypertension control

The George Institute for Global Health0 个研究点目标入组 700 人开始时间: 2012年10月19日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
700

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • * The investigator is satisfied that the patient has persistent hypertension (SBP>140mmHg and/or DBP>90mmHg; or SBP>130mmHg and/or DBP>80mmHg in patients with diabetes mellitus or chronic kidney disease) requiring initiation of pharmacological treatment (in patients not taking drug therapy) or up-titration of pharmacological treatment (in patients taking single drug therapy)
  • *Trial Investigator is unsure as to whether a Triple Pill based therapy or usual care is better.

排除标准

  • *on 2 or more BP lowering drugs
  • * severe or uncontrolled hypertension (SBP > 180mmHg and/or DBP > 110 mmHg)
  • *Accelerated hypertension or hypertension at a level where the physician feels that slower up-titration of treatment is appropriate (e.g. elderly patients)
  • *Contraindication to any of the components of the Triple Pill
  • *Pregnancy, breast feeding, childbearing potential not on effective medically accepted method of child birth control.
  • *Unstable medical condition or known situation where medication regimen might be altered for a significant length of time, e.g. current acute cardiovascular event, planned coronary bypass graft operation, dialysis.
  • *Participants with clinically significant abnormal laboratory value judged to be unsuitable for trial participation by the investigator.

研究者

相似试验